Tag : AbbVie

Clinical Research, Pharma & Healthcare Financing

AbbVie Presents Phase 2 Data for ELAHERE® in Ovarian Cancer

PR Newswire
by PR Newswire07
AbbVie (NYSE: ABBV) today announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented in an oral session at the 2026 Society of...